Tolvaptan CAS 150683-30-0 API Puritas >99.0% (HPLC)
| Nomen | Tolvaptan |
| Nomen chemicum | N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide |
| CAS Number | 150683-30-0 |
| CATTUS Number | RF-API101 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C26H25ClN2O3 |
| M. Pondus | 448.94 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Off-White Crystalline pulveris |
| Lepidium sativum Methodi | IR, HPLC |
| Solubilitas | Solutum in Benzyl Vocatus et Methanol sed fere insolubile in aqua et hexane |
| Puritas / Analysis Methodus | >99.0% (HPLC) |
| Liquescens punctum | 219.0~222.0℃ |
| Damnum in Siccatio | <0.50% |
| Residere in Ignition | <0.10% |
| una immunditia | <0.50% |
| Totalis immunditias | <1.00% |
| Metalla gravis | ≤20ppm |
| RELICTUM Solvents | Occursum Specification |
| Test Standard | Enterprise Standard |
| Consuetudinem | API;Pharmaceutical intermedia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Tolvaptan (CAS: 150683-30-0), etiam quae OPC-41061 nota est, vasopressinum argininium collectivum receptaculum 2 adversariorum ad hyponatremiam (humilem sanguinis gradus natrii tractandam) associatum cum defectu cordis congestivo, cirrhosi et syndrome of. Inconvenienter antidiuretic hormone (SIADH).Otsuka pharmaceutica licentiatus tolvaptan sub nomine artis Samsca post FDA medicamentum mense Maio 2009 approbavit. Tolvaptan etiam efficaciam contra morbum renum polycysticum ostendit.In anno 2004 probatio, tolvaptan cum traditionibus diureticis administrata notata est ad excretionem excessuum humorum augendam et ad emendandum gradus sanguinis sodium in patientibus cordis defectum, sine effectibus laterum producendis sicut hypotensio (pressionis sanguinis humilis) vel hypokalemia (sanguinis gradus potassii diminuti).Medicamentum etiam nullum effectum adversae in renibus exhibebat.
![7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3](https://www.ruifuchemical.com/uploads/7-Chloro-1234-tetrahydrobenzobazepin-5-one-CAS-160129-45-3-300x300.jpg)
